1.
Tenda ED, Andrian S, Albert S, Asaf MM, Pitoyo CW, Setiati S, Subekti I. The Importance of the Timing of Tocilizumab Administration in Moderate to Severely Ill COVID-19: Single Centered Experience Case series. Acta Med Indones [Internet]. 2021Oct.4 [cited 2025May12];53(3):319. Available from: https://actamedindones.org/index.php/ijim/article/view/1854